Benjamin J. Zeskind
IMRXBenjamin J. Zeskind serves as director, officer: PRESIDENT AND CEO at Immuneering Corporation (IMRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Benjamin J. Zeskind's Insider Trading at Immuneering Corporation (IMRX)
Buys
7 · $254.5K
Sells
0 · $0.00
Total Shares Bought
60,581
Total Shares Sold
0
Related Insiders
Brett Matthew Hall
officer: CHIEF SCIENTIFIC OFFICER
IMRXBuy · Jun 16, 2026
Thomas J. Schall
Director
IMRXBuy · Jan 20, 2026
Harold Eugene Brakewood
Chief Business Officer
IMRXBuy · Jan 16, 2026
Leah R Neufeld
officer: CHIEF PEOPLE OFFICER
IMRXBuy · Jan 15, 2026
Peter Feinberg
Director
IMRXBuy · Jan 14, 2026
Michael Bookman
CHIEF LEGAL OFFICER, SECRETARY
IMRXBuy · Oct 1, 2025
Mallory Morales
Chief Accounting Officer
IMRXBuy · Oct 1, 2025